http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110478338-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b108a1250d61a8088fca2015478ab87
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_177489b47ec698dec251da4c02c18990
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_567daa83c7d8b0c91e75ce6b02452048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_513d05b35196548bf59e01b61dd04d7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d3e45145a6688d3a2e1d56b54e11f87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29f88dd03f258da4328bb5752d66487b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_070ccb29b499dd0c59500b916fbed5e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff88c6a156ff75cc514787ce2c666c13
publicationDate 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110478338-A
titleOfInvention Butyrolactone, which is metabolized ketone I, is reducing the application in blood lipid
abstract The invention belongs to pharmaceutical technology field, specially a kind of noval chemical compound and its application, the compound are that butyrolactone is metabolized ketone I, and related application is the application being used to prepare in treatment high blood cholesterol drug about compound butyrolactone metabolism ketone I.Butyrolactone metabolism ketone I can significantly reduce total cholesterol in serum, total triglyceride, total low-density lipoprotein content, while can be improved total HDL content.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112294781-A
priorityDate 2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08989
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID33178
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07492
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID33178
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63153
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Y4Z0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63152
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47851
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ863C3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9PS30
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414642285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506595
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8R1I2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51340302
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01295
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24393
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454

Total number of triples: 46.